Sort
85,873 grants matching “alzheimers”
Biospecimen Core
$10,682,132Bharat Thyagarajan · Washington University · U19 · FY2022 · AG
PRagmatic EValuation of evENTs And Benefits of Lipid-lowering in oldEr Adults (PREVENTABLE)
$10,663,839Karen P Alexander · Duke University · U19 · FY2019 · AG
Prevention of Alzheimer's disease in women: risks and benefits of hormone therapy
$10,638,873Kejal Kantarci · Mayo Clinic Rochester · RF1 · FY2017 · AG
ARIC Neurocognitive Study (ARIC-NCS) Renewal
$10,619,383Josef Coresh · Johns Hopkins University · U01 · FY2020 · HL
Center for Alzheimer's and Related Dementias (CARD): Harmonized Data-Derived Resources for the Alzheimer's Disease and Related Dementias Community
$10,608,860Andrew Singleton · National Institute On Aging · ZIA · FY2021 · AG
Alzheimer's Disease Cooperative Study (ADCS)
$10,534,032Paul S. Aisen · University Of California, San Diego · U01 · FY2007 · AG
Cognitive training to reduce incidence of cognitive impairment in older adults
$10,506,386Jennifer Lee O'Brien · University Of South Florida · R01 · FY2024 · AG
Alzheimer's Disease Cooperative Study (ADCS)
$10,488,248Paul S. Aisen · University Of California, San Diego · U01 · FY2008 · AG
PRagmatic EValuation of evENTs And Benefits of Lipid-lowering in oldEr Adults (PREVENTABLE)
$10,487,354Karen P Alexander · Duke University · U19 · FY2025 · AG
ED-LEAD: Emergency Departments LEading the transformation of Alzheimer's and Dementia care
$10,442,201Joshua Chodosh · New York University School Of Medicine · U19 · FY2023 · AG
Data Collection, Linkages, Cleaning and Sharing Core
$10,425,588James R Wagner · University Of Michigan At Ann Arbor · U54 · FY2024 · AG
Wisconsin longitudinal study: Initial lifetime's impact on Alzheimer's disease and related disorders (WLS-ILIAD)
$10,293,461Sanjay Asthana · University Of Wisconsin-Madison · R01 · FY2025 · AG
New York Center for Collaborative Research in Common Disease Genomics
$10,283,751Robert B Darnell · New York Genome Center · UM1 · FY2017 · HG
National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD)
$10,257,187Tatiana M. Foroud · Indiana University Indianapolis · U24 · FY2023 · AG
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study to Evaluate the Safety and Efficacy of CT1812 in Subjects with Dementia with Lewy Bodies
$10,254,288Anthony O Caggiano · Cognition Therapeutics, Inc. · R01 · FY2022 · AG
Recruitment and Retention for Alzheimer's Disease Diversity Genetic Cohorts in the ADSP (READD-ADSP)
$10,182,247Margaret A Pericak-Vance · University Of Miami School Of Medicine · U19 · FY2024 · AG
ALZHEIMER'S DISEASE COOPERATIVE STUDY
$10,105,572University Of California San Diego · U01 · FY2001 · AG
Data Collection, Linkages, Cleaning and Sharing Core
$10,041,271James R Wagner · University Of Michigan At Ann Arbor · U54 · FY2023 · AG
Alzheimer's Disease Cooperative Study
$10,006,406Howard Feldman · University Of California, San Diego · U19 · FY2016 · AG
The Clinical Significance of Incidental White Matter Lesions on MRI Amongst a Diverse Population with Cognitive Complaints (INDEED)
$10,005,568Charles Decarli · University Of California At Davis · U19 · FY2024 · NS
New York Center for Collaborative Research in Common Disease Genomics
$10,000,000Robert B Darnell · New York Genome Center · UM1 · FY2016 · HG
New York Center for Collaborative Research in Common Disease Genomics
$10,000,000Thomas P Maniatis · New York Genome Center · UM1 · FY2019 · HG
Long-read DNA sequencing of Alzheimers Disease and Related Dementias cases
$9,987,628Andrew Singleton · National Institute On Aging · ZIA · FY2022 · AG
Wisconsin Registry for Alzheimer's Prevention
$9,950,587Sterling C Johnson · University Of Wisconsin-Madison · R01 · FY2023 · AG
National Alzheimer's Coordinating Center
$9,912,441Walter A Kukull · University Of Washington · U24 · FY2024 · AG